1. Home
  2. JGH vs MGTX Comparison

JGH vs MGTX Comparison

Compare JGH & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JGH
  • MGTX
  • Stock Information
  • Founded
  • JGH 2014
  • MGTX 2015
  • Country
  • JGH United States
  • MGTX United States
  • Employees
  • JGH N/A
  • MGTX N/A
  • Industry
  • JGH Investment Managers
  • MGTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • JGH Finance
  • MGTX Health Care
  • Exchange
  • JGH Nasdaq
  • MGTX Nasdaq
  • Market Cap
  • JGH 294.4M
  • MGTX 282.3M
  • IPO Year
  • JGH N/A
  • MGTX N/A
  • Fundamental
  • Price
  • JGH $12.63
  • MGTX $4.42
  • Analyst Decision
  • JGH
  • MGTX Strong Buy
  • Analyst Count
  • JGH 0
  • MGTX 2
  • Target Price
  • JGH N/A
  • MGTX $26.00
  • AVG Volume (30 Days)
  • JGH 73.9K
  • MGTX 218.3K
  • Earning Date
  • JGH 01-01-0001
  • MGTX 08-08-2024
  • Dividend Yield
  • JGH 9.85%
  • MGTX N/A
  • EPS Growth
  • JGH N/A
  • MGTX N/A
  • EPS
  • JGH N/A
  • MGTX N/A
  • Revenue
  • JGH N/A
  • MGTX $697,000.00
  • Revenue This Year
  • JGH N/A
  • MGTX N/A
  • Revenue Next Year
  • JGH N/A
  • MGTX $447.29
  • P/E Ratio
  • JGH N/A
  • MGTX N/A
  • Revenue Growth
  • JGH N/A
  • MGTX N/A
  • 52 Week Low
  • JGH $10.36
  • MGTX $3.49
  • 52 Week High
  • JGH $12.85
  • MGTX $7.60
  • Technical
  • Relative Strength Index (RSI)
  • JGH 41.80
  • MGTX 47.28
  • Support Level
  • JGH $12.75
  • MGTX $4.55
  • Resistance Level
  • JGH $12.95
  • MGTX $5.12
  • Average True Range (ATR)
  • JGH 0.13
  • MGTX 0.26
  • MACD
  • JGH -0.02
  • MGTX 0.08
  • Stochastic Oscillator
  • JGH 14.63
  • MGTX 43.44

About JGH Nuveen Global High Income Fund of Beneficial Interest

Nuveen Global High Income Fund operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of current income. Its securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Share on Social Networks: